Per Clauson

2.6k total citations · 1 hit paper
26 papers, 1.9k citations indexed

About

Per Clauson is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Per Clauson has authored 26 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Per Clauson's work include Diabetes Management and Research (17 papers), Diabetes Treatment and Management (14 papers) and Pancreatic function and diabetes (9 papers). Per Clauson is often cited by papers focused on Diabetes Management and Research (17 papers), Diabetes Treatment and Management (14 papers) and Pancreatic function and diabetes (9 papers). Per Clauson collaborates with scholars based in Denmark, Sweden and United States. Per Clauson's co-authors include Tadeusz Dereziński, Melanie J. Davies, Kjeld Hermansen, Philip Home, Elaine Brohan, Robyn von Maltzahn, D Wild, Torsten Christensen, Linda Gonder‐Frederick and V. Roberts and has published in prestigious journals such as Diabetes Care, Diabetes and Journal of the American Geriatrics Society.

In The Last Decade

Per Clauson

26 papers receiving 1.8k citations

Hit Papers

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Co... 2006 2026 2012 2019 2006 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes
    2006 497 citations Melanie J. Davies, Tadeusz Dereziński et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Per Clauson Denmark 18 1.7k 561 434 413 136 26 1.9k
Julie Rask Larsen Denmark 16 664 0.4× 284 0.5× 220 0.5× 141 0.3× 166 1.2× 28 1.1k
Alexandre Wajngot Sweden 19 593 0.3× 412 0.7× 164 0.4× 431 1.0× 39 0.3× 40 1.2k
Deborah Hinnen United States 12 809 0.5× 216 0.4× 130 0.3× 172 0.4× 58 0.4× 25 961
Louise Færch Denmark 7 720 0.4× 240 0.4× 67 0.2× 279 0.7× 414 3.0× 16 930
Meera Shah United States 16 438 0.3× 542 1.0× 73 0.2× 167 0.4× 114 0.8× 38 1.0k
Trine Vang Skjøth Denmark 12 1.1k 0.6× 344 0.6× 48 0.1× 384 0.9× 614 4.5× 23 1.3k
A. W. Patrick United Kingdom 14 443 0.3× 168 0.3× 149 0.3× 93 0.2× 35 0.3× 35 708
Joergen Rungby Denmark 10 577 0.3× 350 0.6× 44 0.1× 307 0.7× 98 0.7× 11 802
Ee Lin Lim United Kingdom 7 449 0.3× 376 0.7× 77 0.2× 185 0.4× 80 0.6× 11 949
Alison C. Barnes United Kingdom 15 482 0.3× 401 0.7× 82 0.2× 144 0.3× 89 0.7× 25 933

Countries citing papers authored by Per Clauson

Since Specialization
Citations

This map shows the geographic impact of Per Clauson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Clauson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Clauson more than expected).

Fields of papers citing papers by Per Clauson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Clauson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Clauson. The network helps show where Per Clauson may publish in the future.

Co-authorship network of co-authors of Per Clauson

This figure shows the co-authorship network connecting the top 25 collaborators of Per Clauson. A scholar is included among the top collaborators of Per Clauson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Clauson. Per Clauson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Onishi, Yukiko, Yasuhiko Iwamoto, Soon Jib Yoo, et al.. (2013). Insulin degludec compared with insulin glargine in insulin‐naïve patients with type 2 diabetes: A 26‐week, randomized, controlled, Pan‐Asian, treat‐to‐target trial. Journal of Diabetes Investigation. 4(6). 605–612. 92 indexed citations
3.
Iwamoto, Yasuhiko, Per Clauson, Tomoyuki Nishida, & Kohei Kaku. (2012). Insulin degludec in Japanese patients with type 1 diabetes mellitus: A randomized controlled trial. Journal of Diabetes Investigation. 4(1). 62–68. 13 indexed citations
4.
Seino, Yutaka, Mads Frederik Rasmussen, Per Clauson, & Kohei Kaku. (2012). The once‐daily human glucagon‐like peptide‐1 analog, liraglutide, improves β‐cell function in Japanese patients with type 2 diabetes. Journal of Diabetes Investigation. 3(4). 388–395. 16 indexed citations
5.
6.
Davies, Melanie J., et al.. (2008). Reduced Weight Gain with Insulin Detemir Compared to NPH Insulin Is Not Explained by a Reduction in Hypoglycemia. Diabetes Technology & Therapeutics. 10(4). 273–277. 38 indexed citations
7.
Köhler, Gerd, Stefan Korsatko, Andrea Wutte, et al.. (2007). The effect of exercise on the absorption of inhaled human insulin in healthy volunteers. British Journal of Clinical Pharmacology. 65(2). 165–171. 5 indexed citations
8.
Wild, D, Robyn von Maltzahn, Elaine Brohan, et al.. (2007). A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Education and Counseling. 68(1). 10–15. 406 indexed citations
9.
Garber, Alan J., et al.. (2007). Lower Risk of Hypoglycemia with Insulin Detemir than with Neutral Protamine Hagedorn Insulin in Older Persons with Type 2 Diabetes: A Pooled Analysis of Phase III Trials. Journal of the American Geriatrics Society. 55(11). 1735–1740. 40 indexed citations
10.
Köhler, Gerd, Stefan Korsatko, Andrea Wutte, et al.. (2007). The Effect of Exercise on the Absorption of Inhaled Human Insulin via the AERx Insulin Diabetes Management System in People With Type 1 Diabetes. Diabetes Care. 30(10). 2571–2576. 1 indexed citations
11.
Jones, David, et al.. (2006). Less glucose variability with insulin detemir compared to NPH insulin in subjects with type 1 diabetes undergoing continuous glucose monitoring. Diabetes. 55. 1 indexed citations
12.
Laursen, Torben, et al.. (2006). The impact of large tidal volume ventilation on the absorption of inhaled insulin in rabbits. European Journal of Pharmaceutical Sciences. 30(3-4). 351–357. 2 indexed citations
13.
Philis‐Tsimikas, Athena, et al.. (2006). Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly Controlled Type 2 Diabetes. Clinical Therapeutics. 28(10). 1569–1581. 235 indexed citations
14.
McElduff, Aidan, Laurence E. Mather, Peter Kam, & Per Clauson. (2005). Influence of acute upper respiratory tract infection on the absorption of inhaled insulin using the AERx® insulin Diabetes Management System. British Journal of Clinical Pharmacology. 59(5). 546–551. 34 indexed citations
15.
Cramer, Joyce A., et al.. (2004). Compliance with Inhaled Insulin Treatment Using the AERx ® iDMS Insulin Diabetes Management System. Diabetes Technology & Therapeutics. 6(6). 800–807. 18 indexed citations
16.
Thipphawong, John, Babatunde Otulana, Per Clauson, Jerry Okikawa, & Stephen J. Farr. (2002). Pulmonary Insulin Administration Using the AERx ® Insulin Diabetes System. Diabetes Technology & Therapeutics. 4(4). 499–504. 24 indexed citations
17.
Clauson, Per, et al.. (1998). Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden. Scandinavian Journal of Clinical and Laboratory Investigation. 58(4). 353–360. 69 indexed citations
18.
19.
Clauson, Per & Birgitta Linde. (1995). Absorption of Rapid-Acting Insulin in Obese and Nonobese NIDDM Patients. Diabetes Care. 18(7). 986–991. 42 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie Rask Larsen Breakdown of academic impact, for papers by Alexandre Wajngot Breakdown of academic impact, for papers by Deborah Hinnen Breakdown of academic impact, for papers by Louise Færch Breakdown of academic impact, for papers by Meera Shah Breakdown of academic impact, for papers by Trine Vang Skjøth Breakdown of academic impact, for papers by A. W. Patrick Breakdown of academic impact, for papers by Joergen Rungby Breakdown of academic impact, for papers by Ee Lin Lim Breakdown of academic impact, for papers by Alison C. Barnes
Rankless by CCL
2026